News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

3 drugmakers dominated opioid supplies as 76B pills flooded the U.S.: report

As the nation’s opioid epidemic spiraled out of control at the turn of the decade, parts of rural America seemed awash in prescription drugs. But the extent to which drug distributors and manufacture
2019/7/17
Seattle Genetics investors breathe a sigh of relief as Adcetris posts 30% sales growth

IfSeattle Genetics'second-quarter earnings report is any indication, the company's lead product is finally living up to its potential. The companyunveiledthat sales of cancer drug Adcetris jumped 30%
2019/7/16
Earnings bulletin: Johnson & Johnson's second quarter of 2019

Johnson & Johnson kicked off the second-quarter earnings season Tuesday, reporting that its pharma unitoutperformedstruggling consumer healthcare and medical device segments. Pharma posted sales
2019/7/16
Thanks to patent win, Amgen ready to kick PCSK9 rivals Sanofi, Regeneron off the market in Germany

Amgen and its PCSK9 rivals Sanofi and Regeneron have been battling over U.S. patents for years, but this week Amgen scored a win in Germany—and it's the sort of win the company would like to duplic
2019/7/15
Emgality maker Lilly courts payers with new migraine ER data

Sales of Eli Lilly’s migraine and cluster headache med Emgalityhave lagged behind competitors from Amgen and Novartis and Teva Pharmaceutical. And in its push to bring payers on board, Lilly is deplo
2019/7/15
Gilead snags Lilly exec Shaw for Kite CEO position

Back in May, new Gilead Sciences CEO Daniel O’Day said he’d be looking for a CEO for Gilead’s Kite unit. And he’s found his pick. Thursday, the Big Biotech said it wouldbring onEli Lilly executive Ch
2019/7/12
Indivior's former parent ponies up a whopping $1.4B to settle Suboxone marketing probe

With the feds sniffing around Indivior’s aggressive marketing of its opioid addiction treatment Suboxone, the forecast looked bleak for the drugmaker. The stink was bad enough that Indivior’s former
2019/7/12
Pharma Alnylam recruits former Shire exec to replace departing CFO Soni

It’s been less than two years since former Shire CFO Jeff Poulton left the biopharma world, but he’s back—and he’s landed at Alnylam. In replacing current financial chief Manmeet Soni, Poulton will h
2019/7/11
Lilly Bio-Medicines chief Christi Shaw steps aside, leaving key launches behind

Early into an important launch for Emgality and amid rollouts for other key meds, Eli Lilly Bio-Medicines chief Christi Shaw is stepping aside. Shaw will workwith the drugmaker through the end
2019/7/11
Sorry, pharma: White House pulls industry's favored rebate proposal

When the Trump administration rolled out its proposal to dramatically reshape drug rebates last year, the pharma industry cheered. Analysts figured the move wouldspread to private plans, too.
2019/7/10

Excipients